Clinical trial
Effectiveness of GABA Agonists in Reducing the Reinforcing Effects of Cocaine
NCT00218166 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00218166 |
|---|---|
| Title | Effectiveness of GABA Agonists in Reducing the Reinforcing Effects of Cocaine |
| Official title | GABA Agonists as Pharmacotherapies for Cocaine Abuse |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cocaine-Related Disorders |
| Intervention type | Drug |
| Interventions | GABA Agonists |
| Enrollment | 78 |
| Start date | Aug 1, 2001 |
| Primary completion | May 1, 2005 |
| Completion | May 1, 2005 |
| First posted | Sep 22, 2005 |
| Last update posted | Jan 11, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: